Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cambridge Innovation Capital (CIC) is a venture capital firm founded in 2014 and based in Cambridge, UK. The organization specializes in early-stage investments in life sciences and deep tech sectors, utilizing its strong ties with the University of Cambridge to identify and support innovative companies. CIC aims to foster the growth of startups by providing not only capital but also technical expertise and strategic guidance.
CIC primarily invests in early-stage companies, focusing on Seed through Series A funding. The firm supports entrepreneurs in balancing technology development with business growth, particularly in sectors such as cancer therapy, genomic diagnosis, surgical robotics, artificial intelligence, and quantum computing. CIC also offers later-stage support through opportunity and growth funds, providing scale-up capital.
CIC's portfolio includes notable companies such as: - **Cambridge GaN Devices**: Focuses on sustainable power electronics. - **Pragmatic Semiconductor**: Innovates in semiconductor technology and manufacturing. - **Riverlane**: Develops error correction technology for quantum computing. - **Microbiotica**: Works on microbiome-based treatments. - **BeyondMath**: Aims to unlock innovation through generative physics. - **Cytora**: Powers digital insurance solutions. - **TRIMTECH Therapeutics**: Targets neurodegenerative diseases.
To approach Cambridge Innovation Capital, founders should prepare a clear and concise pitch that highlights their technology and business model. Interested parties can submit their pitches through the firm's website at cic.vc or directly via email at enquiries@cic.vc.
It's advisable to emphasize how your startup aligns with CIC's focus on life sciences and deep tech innovations.
Recently, Cambridge Innovation Capital committed GBP 100 million to support University of Cambridge spinouts through a new Entrepreneur-in-Residence program. This initiative aims to enhance the growth of innovative startups emerging from the university's ecosystem.
The firm has also launched a new GBP 250 million fund, further solidifying its position as a key player in the venture capital landscape focused on technology and life sciences.
Cambridge Innovation Capital primarily invests in early-stage companies, focusing on Seed through Series A funding.
You can pitch Cambridge Innovation Capital by visiting their website at cic.vc or by emailing them at enquiries@cic.vc.
CIC focuses on sectors such as biotech, artificial intelligence, robotics, healthcare, genomics, and drug discovery.
The firm typically invests between $1 million and $10 million in its portfolio companies.
CIC invests primarily in the United Kingdom and Europe.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.